comprehensive -WSS

comprehensive

author：explore 2025-09-30 00:46:28 - browse：9456

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO Tariq Kassum, it’s proving to be more difficult than he anticipated.

That’s because in recent days, Celsius, based in Cambridge, Mass., has been forced to conduct a round of layoffs, sources told STAT. Kassum confirmed around 75% of Celsius’ 40-person team had been laid off, and disclosed that the biotech has also been quietly paring back its pipeline this year. It shut down almost all early-stage research projects, including pausing all of its cancer drug work, in order to conserve enough cash for the Phase 1 trial it announced this week.

“It’s an incredibly bittersweet moment.… The cognitive dissonance there is just really, really hard,” Kassum told STAT. “But I do think that you’re seeing a lot of other companies doing what we are, which is, as painful as it is, to focus on the nearest term value drivers, the things that can get to patients the quickest, and make the painful decisions that allow you to live to fight another day.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Medical device trials still don't enroll enough women, study finds

Wikipedia

hotspot

WSS

Study: Why relieving medical debt did not improve financial outcomes

NIH tests clinical research in primary care with $30 million program

Report captures long Covid’s disabling effects and policy challenges

New report analyzes digital physical therapy solutions' effectiveness

Crinetics acromegaly drug succeeds in late

ALS patient reclaims some autonomy thanks to wearable 'robot'

knowledge

comprehensive

hotspot

Hollywood unions extend contract negotiations for actors

How generative AI is inspiring dreams of a health data revolution

What does generative AI mean for health care? We asked experts

Readers discuss the intersection of pregnancy and addiction

Guidelines to prevent youth baseball injuries need more muscle

Listen: Biogen's potential pivot, & Illumina's next chapter

As demand for Covid shots wanes, Moderna seeks its next success

Report captures long Covid’s disabling effects and policy challenges

Walensky prepares to leave CDC — and Congress — behind

ALS patient reclaims some autonomy thanks to wearable 'robot'

entertainment

Amazon on where the company's health care bets are headed next

The 10 drugs up first for Medicare price negotiation

My daughter's legacy lives on through her writing, phage therapy

Medical device trials still don't enroll enough women, study finds

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

ALS patient reclaims some autonomy thanks to wearable 'robot'

explore

Wikipedia

hotspot

hotspot